• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

在人类乳腺癌中表达的新型蛋白激酶。

Novel protein kinases expressed in human breast cancer.

作者信息

Cance W G, Craven R J, Weiner T M, Liu E T

机构信息

Department of Surgery, Lineberger Comprehensive Cancer Center, University of North Carolina School of Medicine, Chapel Hill 27599.

出版信息

Int J Cancer. 1993 Jun 19;54(4):571-7. doi: 10.1002/ijc.2910540409.

DOI:10.1002/ijc.2910540409
PMID:8099900
Abstract

The family of protein kinases includes many oncogenes and growth-factor receptors, as well as genes that are involved in cell-cycle regulation. We have identified protein kinases expressed in a human breast-cancer cell line, 600PEI, and a primary human breast carcinoma, using PCR cloning techniques based on consensus sequences in the kinase domain. Twenty-five different protein kinases were isolated, including 3 novel putative tyrosine kinases (designated TK1, TK2, and TK5), and 2 novel putative cell-cycle-associated serine/threonine kinases (designated STK1 and STK2). TK1 is a new member of the src family of kinases that is expressed predominantly in epithelial cells. TK2 is homologous to the receptor kinase, HEK, and TK5 appears to be another member of the JAK family of kinases. The novel serine/threonine kinases, designated STK1 and STK2, were homologous to the human cdc2 and the Aspergillus nimA genes. We subsequently analyzed the levels of expression of all of these protein kinases in a panel of human breast carcinomas, using PCR-based methods. This analysis revealed different expression profiles in different primary breast carcinomas and, therefore, may determine new molecular sub-sets of human breast cancer.

摘要

蛋白激酶家族包括许多癌基因和生长因子受体,以及参与细胞周期调控的基因。我们利用基于激酶结构域共有序列的PCR克隆技术,在人乳腺癌细胞系600PEI和原发性人乳腺癌中鉴定出了表达的蛋白激酶。分离出了25种不同的蛋白激酶,包括3种新的假定酪氨酸激酶(命名为TK1、TK2和TK5),以及2种新的假定细胞周期相关丝氨酸/苏氨酸激酶(命名为STK1和STK2)。TK1是src激酶家族的新成员,主要在上皮细胞中表达。TK2与受体激酶HEK同源,TK5似乎是JAK激酶家族的另一个成员。命名为STK1和STK2的新型丝氨酸/苏氨酸激酶与人cdc2和曲霉nimA基因同源。随后,我们使用基于PCR的方法分析了一组人乳腺癌中所有这些蛋白激酶的表达水平。该分析揭示了不同原发性乳腺癌中的不同表达谱,因此可能确定人乳腺癌的新分子亚组。

相似文献

1
Novel protein kinases expressed in human breast cancer.在人类乳腺癌中表达的新型蛋白激酶。
Int J Cancer. 1993 Jun 19;54(4):571-7. doi: 10.1002/ijc.2910540409.
2
Two novel human serine/threonine kinases with homologies to the cell cycle regulating Xenopus MO15, and NIMA kinases: cloning and characterization of their expression pattern.两种与调节细胞周期的非洲爪蟾MO15及NIMA激酶具有同源性的新型人类丝氨酸/苏氨酸激酶:其表达模式的克隆与特征分析
Oncogene. 1994 Jul;9(7):1977-88.
3
Protein kinases in human breast cancer.人类乳腺癌中的蛋白激酶
Breast Cancer Res Treat. 1995 Jul;35(1):105-14. doi: 10.1007/BF00694751.
4
Analysis of tyrosine kinase mRNAs including four FGF receptor mRNAs expressed in MCF-7 breast-cancer cells.对包括在MCF-7乳腺癌细胞中表达的四种成纤维细胞生长因子受体(FGF受体)mRNA在内的酪氨酸激酶mRNA的分析。
Int J Cancer. 1992 Feb 20;50(4):598-603. doi: 10.1002/ijc.2910500419.
5
Nek8, a NIMA family kinase member, is overexpressed in primary human breast tumors.Nek8是一种NIMA家族激酶成员,在原发性人类乳腺肿瘤中过表达。
Gene. 2004 Mar 17;328:135-42. doi: 10.1016/j.gene.2003.12.002.
6
Activity and substrate specificity of the murine STK2 Serine/Threonine kinase that is structurally related to the mitotic regulator protein NIMA of Aspergillus nidulans.与构巢曲霉有丝分裂调节蛋白NIMA结构相关的小鼠STK2丝氨酸/苏氨酸激酶的活性和底物特异性。
Biochem Biophys Res Commun. 1999 Oct 22;264(2):449-56. doi: 10.1006/bbrc.1999.1536.
7
Identification of 21 novel human protein kinases, including 3 members of a family related to the cell cycle regulator nimA of Aspergillus nidulans.鉴定出21种新型人类蛋白激酶,其中包括与构巢曲霉细胞周期调节因子nimA相关的一个家族的3个成员。
Cell Growth Differ. 1993 Oct;4(10):821-30.
8
Rak, a novel nuclear tyrosine kinase expressed in epithelial cells.Rak,一种在上皮细胞中表达的新型核酪氨酸激酶。
Cell Growth Differ. 1994 Dec;5(12):1347-55.
9
Protein kinases in normal and transformed melanocytes.正常和转化黑素细胞中的蛋白激酶。
Melanoma Res. 1994 Oct;4(5):313-9. doi: 10.1097/00008390-199410000-00008.
10
Complete nucleotide sequence, expression, and chromosomal localisation of human mixed-lineage kinase 2.人类混合谱系激酶2的完整核苷酸序列、表达及染色体定位
Eur J Biochem. 1995 Dec 1;234(2):492-500. doi: 10.1111/j.1432-1033.1995.492_b.x.

引用本文的文献

1
Targeting protein tyrosine kinase 6 in cancer.靶向蛋白酪氨酸激酶 6 治疗癌症。
Biochim Biophys Acta Rev Cancer. 2020 Dec;1874(2):188432. doi: 10.1016/j.bbcan.2020.188432. Epub 2020 Sep 18.
2
miR-19 promotes the proliferation of clear cell renal cell carcinoma by targeting the FRK-PTEN axis.微小RNA-19通过靶向FRK-PTEN轴促进肾透明细胞癌的增殖。
Onco Targets Ther. 2019 Apr 10;12:2713-2727. doi: 10.2147/OTT.S199238. eCollection 2019.
3
Tyrosine kinase receptor TIE-1 mediates platinum resistance by promoting nucleotide excision repair in ovarian cancer.
酪氨酸激酶受体 TIE-1 通过促进卵巢癌中的核苷酸切除修复来介导铂类耐药性。
Sci Rep. 2018 Sep 4;8(1):13207. doi: 10.1038/s41598-018-31069-2.
4
Breast Cancer Malignant Processes are Regulated by Pax-5 Through the Disruption of FAK Signaling Pathways.乳腺癌恶性进程由Pax-5通过破坏粘着斑激酶信号通路来调控。
J Cancer. 2016 Oct 22;7(14):2035-2044. doi: 10.7150/jca.15200. eCollection 2016.
5
New interaction partners for Nek4.1 and Nek4.2 isoforms: from the DNA damage response to RNA splicing.Nek4.1 和 Nek4.2 同工型的新相互作用伙伴:从 DNA 损伤反应到 RNA 剪接。
Proteome Sci. 2015 Feb 26;13:11. doi: 10.1186/s12953-015-0065-6. eCollection 2015.
6
Antagomir-1290 suppresses CD133⁺ cells in non-small cell lung cancer by targeting fyn-related Src family tyrosine kinase.抗miR-1290通过靶向Fyn相关的Src家族酪氨酸激酶抑制非小细胞肺癌中的CD133⁺细胞。
Tumour Biol. 2015 Aug;36(8):6223-30. doi: 10.1007/s13277-015-3307-4. Epub 2015 Mar 18.
7
"Stop Ne(c)king around": How interactomics contributes to functionally characterize Nek family kinases.“别再胡闹了”:相互作用组学如何助力对Nek家族激酶进行功能表征。 (注:原文中Ne(c)king around可能是一种不太正式、带有调侃或形象说法的表达,这里直译为“胡闹”,整体翻译尽量贴合原文风格和意思)
World J Biol Chem. 2014 May 26;5(2):141-60. doi: 10.4331/wjbc.v5.i2.141.
8
RAKing in AKT: a tumor suppressor function for the intracellular tyrosine kinase FRK.在AKT中称王:细胞内酪氨酸激酶FRK的肿瘤抑制功能
Cell Cycle. 2009 Sep 1;8(17):2728-32. doi: 10.4161/cc.8.17.9389. Epub 2009 Sep 29.
9
A new identity for MLK3 as an NIMA-related, cell cycle-regulated kinase that is localized near centrosomes and influences microtubule organization.MLK3作为一种与NIMA相关、细胞周期调控的激酶的新身份,该激酶定位于中心体附近并影响微管组织。
Mol Biol Cell. 2003 Jan;14(1):156-72. doi: 10.1091/mbc.e02-02-0115.
10
Kinase inhibitors in cancer therapy: a look ahead.癌症治疗中的激酶抑制剂:展望未来。
Drugs. 2000 Mar;59(3):435-76. doi: 10.2165/00003495-200059030-00004.